Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CDXS
#3601
Codexis, Inc.
2.3
7
USD
+3.04%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+3.04%
Aylık Değişim
+46.30%
6 aylık değişim
-7.78%
Yıllık Değişim
+4.41%
Önceki Kapanış
2.3
0
Open
2.3
7
Bid
Ask
Low
2.3
7
High
2.3
7
Hacim
55
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CDXS
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
64.4 M
65.16 M
65.95 M
70.3 M
82.84 M
90.87 M
—
Valuation ratios
Enterprise value
1.26 B
1.92 B
193.99 M
154.23 M
435.76 M
170.53 M
960.7 M
Price to earnings ratio
—
-94.76
-9.16
-2.79
-5.36
-3.26
-12.23
Price to sales ratio
—
19.27
2.2
3.03
5.9
2.02
13
Price to cash flow ratio
—
-141.52
27.04
-4.04
-7.09
-7.33
-17.61
Price to book ratio
—
12.28
2.11
2.45
5.23
2.81
5.31
Enterprise value to EBITDA ratio
-57.1
-94.77
-6.57
-2.85
-7
-2.66
-13.18
Profitability ratios
Return on assets %
-0.11
-0.09
-0.13
-0.56
-0.44
-0.3
-0.35
Return on equity %
-0.14
-0.13
-0.23
-0.88
-0.98
-0.87
-0.97
Return on invested capital %
-178.54
-105.71
-121.25
-292.59
-347.64
-241.41
-264.45
Gross margin %
80.04
78.47
72.52
81.74
72.55
86.73
316.18
Operating margin %
-34.64
-21.67
-25.17
-97.04
-98.61
-59.3
-548.68
EBITDA margin %
-31.87
-19.35
-21.31
-77.17
-90.44
-52
-506.34
Net margin %
-34.77
-20.31
-24.24
-108.69
-109.99
-62.47
-564.24
Liquidity ratios
Quick ratio
7.34
4.82
3.28
2.53
4.1
3.75
17.1
Current ratio
7.38
4.85
3.32
2.61
4.18
3.82
17.49
Inventory turnover
20.59
20.91
23.85
5.43
7.26
5.16
5.01
Asset turnover
0.37
0.45
0.56
0.36
0.42
0.47
0.52
Solvency ratios
Debt to assets ratio
—
—
—
—
0.4
0.5
2.01
Debt to equity ratio
—
—
—
—
0.89
1.45
5.67
Long term debt to total assets ratio
—
—
—
—
0.19
0.27
1.1
Long term debt to total equity ratio
—
—
—
—
0.43
0.79
3.12
Per share metrics
Operating cash flow per share
—
-0.22
0.17
-0.77
-0.67
-0.22
-0.23
EBIT per share
—
-0.35
-0.53
-1
-0.8
-0.48
-0.49
EBITDA per share
—
-0.31
-0.45
-0.79
-0.73
-0.42
-0.43
Total debt per share
—
—
—
—
0.82
0.84
3.13
Cash per share
—
1.81
1.74
0.96
1
0.9
3.05
Net current asset value per share
—
2.51
2.49
1.37
1.35
1.11
3.94
Tangible book value per share
—
2.5
2.17
1.24
0.88
0.55
2.15
Working capital per share
—
1.99
1.74
0.85
1.02
0.82
3.01
Book value per share
—
2.55
2.22
1.27
0.91
0.58
2.26
Codexis Inc
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Haberler
Benchmark, 4Ç sonuçları sonrası Codexis hissesi için Tut önerisini yineledi
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS)
Stifel, Codexis hissesi için Al tavsiyesini korudu
Cantor Fitzgerald, siRNA anlaşması sonrası Codexis hissesi için tavsiyesini yineledi
Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance
Why Did Codexis (CDXS) Stock Soar Nearly 38% After Hours? - Codexis (NASDAQ:CDXS)
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Codexis kazancı $0,15 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
Codexis earnings beat by $0.15, revenue topped estimates
Liquidia Corporation (LQDA) Surpasses Q4 Earnings and Revenue Estimates